Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
good things to come ? Htds is alive.
I just hold, curious to see the following months.
" I been loading up on this stock for months" for months ????? the volume is decent since ...6 weeks, hummmm strange.... manipulation
Beware. HTDS has been already sold as a shell in 2014 but no change in the price and volume happened. Are you sure you saw HTDS on the link you provide ? there is no new, no update, it is maybe a simple manipulation.
above 0.0050 ????? sorry but based on what ? nothing allows us to think this stock is going to go somewhere.
still one day with a decent volume with no news, no change, no updates, nothing.
Frankly, I don’t know, all we’ve seen in the last month is an unusual increase in volume that we haven’t seen in 10 years. Maybe some news in a near future?
In 1 month = almost 650 millions volume.
65 millions in one trade ??? who is buying ? trade between insiders or not ?
Dont you think we need news ? If it is up without news it would be weird and could go down faster than he grew up. For the moment no news, no filings, no reason to purchase shares, imo. And we are still in the grey market, everything is still unclear, let's hope we will have good informations later.
The first trade at 0.0002 price level for 900 000 shares in...years, wow
yes, it wakes up, it is confirming today by an other good volume of 90 millions or so at 0.0001. In some weeks there was a volume of 320 millions minimum. and now the price is at 0.00015 ???? For the moment still no news, no filings.
agree this volume could explain they load up, I dont see an other explanation. I have this stock since 2009-2010 lol
if you compare with the volume years and months ago you can consider that this volume is increasing daily. Something changes, I hope for the best.
we dont know who is behind it, no news, no filings, no updates. They are on the "expert" market since December 20, 2019.
2 things seem new, the volume has been the largest in long years and the majority of this volume has been traded at a price of 0.0001 (not 0.00001 as before). I don't know if these changes mean anything, but it proves that it's not dead at all.
december volume = 232 millions shares. (188 millions in 2 days)
we cant sell so we hold lol. Curious to see what happens.
who buys today ? Is it possible to buy ?
EPGL became a private company under the name of "Inwith corporation".
Ask to Bausch and Lomb, that is all. hahaha, byebye.
ask to Bausch and Lomb lmfao.
wrong they integrated their technology in SOFT hydrogel contact lens of their partner, Basuch and Lomb, Period.
They wrote only one time "Imwith" instead of "INWITH", only once.
Mojo vision has only HARD smart contact lenses.
Inwith corporation has SOFT smart contact lenses, built with hydrogel, wider market, bigger market, and much more applications on existing Hydrogel devices and ones to comes. Their technology is integrated in their partner's soft hydrogel contact lenses, Bausch and Lomb.
https://www.forbes.com/sites/charliefink/2020/03/09/inwith-puts-smart-tech-in-bausch-and-lomb-lenses/#1f5d689b796a
InWith Corporation, which holds key enabling IP in augmented contact lenses, has been at work with Bausch and Lomb (NYSE: BHC) to develop smart contacts for the past year. InWith plans for an Institutional Review Board approval this year on first prototypes. InWith co-founder and CEO Michael Hayes says the unique marriage marriage of highly biocompatible materials with 3-D flexible microelectronics embedded into molded hydrogel devices, which InWith calls “smart biology,” may be on the market “in the near future.”
XR
The world's first picture of a silicon chip inside a real, soft contact lens. Soon, chips like this ... [+] INWITH
With InWith’s technology, the augmented lens is just like the soft contact lens 150 million people use every day. Except they’re connected to your phone. They harvest energy from the normal blinking of the eyes. Check your blood sugar. Send alerts and notifications. “This opens the door to hundreds of new devices: blood chemistry for cancer and virus detection, drug delivery, artificial organ parts with electronics for movement,” said Hayes in an interview. “This is the next big wave; the merger of the mobile device into the human body for full monitoring of your health. It will lead to less disease and longer lives.”
XR, AR
ImWith diagram illustrating the elements of their system. INWITH
Today In: Consumer Tech
Samsung Confirms Cool Galaxy Watch Feature That Outdoes Apple, But There’s A Catch
Apple Watch Series 6 Leak Details 5 Great Innovations, Including 1 Killer Feature
Apple Loop: iPhone SE Problems, iPhone 12 Price Leaks, MacBook Pro’s Missing Features
Hayes is the co-inventor, with Dr. David Markus PhD, of InWith’s medical device, microelectronics and ophthalmic patents. Some of the patents used are: (1) Energy Harvesting from the blinking human eye to power a contact lens; (2) Defining space inside hydrogel devices such as contacts, for computer circuitry to be embedded during manufacturing; and (3) Smart case for charging smart contact lenses in liquid medium, while not in use. There are more, and some pending.
InWith’s remarkably small team of five has been working alongside a much larger team of scientists on the smart contact lens’ development. “In Bausch and Lomb’s labs, our smart technology is embedded in the Bausch and Lomb ULTRA contacts, which are the best multifocal lenses on the market today.” Said Hayes.
XR
Inventors, and co-founders of ImWith, Michael Hayes and David Markus, PhD, with fellow founders ... [+] IMWITH
“The era of fully monitored health and well-being is coming and it requires biocompatibility mixed with circuitry,” says Hayes. “Won't it be cool when early detection of virus, cancer, etc., will be in micro hydrogel implants that alert your smartphone, like your home has carbon monoxide and smoke detectors? Commonplace.” Hayes says at scale the augmented contacts won’t cost much more than the current contact lenses.
Bausch and Lomb is a leading manufacturer of contact lenses, which is an $18 Bn market. "Bausch + Lomb continuously seeks the latest advancements in eye care technology,” said Arthur Shannon, SVP of Bausch and Lomb.
Last month, Mojo Vision came out of stealth with its own augmented contact lenses. They are doing a pilot with Vista Vision Center of Palo Alto helping sight impaired people navigate low light situations. “The future is wet,” said Hayes. “This is just the DOS phase for this technology. We’re going to have bio implants. It won’t end here.”
XR
Up close with InWith smart contact lens. INWITH
Follow me on Twitter or LinkedIn. Check out my website or some of my other work here.
Charlie Fink
Charlie Fink
Charlie Fink is an AR/VR Consultant, Forbes Columnist, and the Author of "Charlie Fink’s Metaverse, An AR Enabled Guide to VR & AR" (2018) and "Convergence, How The World… Read More
Htds is on sale (as a shell) but it still has the "caveat emptor" mention, they were never able to have it removed.Maybe it will be the case for the new owner of this company.
://www.otcmarkets.com/stock/HTDS/overview
Not sure of what you said, maybe there is a strong NDA in place. in the same time why they announced this prototype if there is a strong NDA. Maybe they were allowed to announce it because the NDA concerned only Inwithcorp and not Epgl so once epgl has been swallowed by Inwith they were under the NDA law, it could explain the announcement followed by this silence now.
I guess you understand that we would want to know if there is a working prototype or not, I am just referring about what they said, a prototype was expected at the end of 2018. So I expected just one word about it, that is all, like " we got it", or "it is ok",....
I admit I dont understand what you mean in your second sentence.
"the reason the company wants the lens, will play a factor for when the news...hits the ol interwebs ".
"The 1st prototype for a marketable smart contact lens,being produced by EPGL Med, with a specific application, and made of silicon hydrogel, is due out this year."
we are now in 2019 so because we have no news about this prototype I guess we should consider it as a failure, no ?
still an overvalued pps, too bad.
with this pps at 0.094 it gives a valuation at more 9 millions, it is overvalued according the financials. Furthermore there is no real volume in buy/sell.
So this stock is more likely to pursue his fall.
Imo.
this stock will go down again, nothing stops his fall.
do we know when this company will have their first published revenues ?
$4 for your shares ? I buy, I have just $4 in my pocket, deal.
??????? Do you mean that Inwith made recently an offer???
Humm the most important is in the facts, inventions are slowly patented, inventions were tested and elaborated in coopervision labs now it is the "integration" phase of the Inwith inventions in leaders labs. Just wait.
it is always good to have some little clues. My only
other tweet from Inwith
InWith's 3D circuitry platform can potentially enable 100's of new biocompatible devices that deliver drugs, diagnose disease,
monitor biomarkers and augment senses, to name a few applications.
"The human augmentation market, which includes implants as well as bionic limbs and fledgling computer-brain connections, will grow more than tenfold, to $2.3 billion, by 2025, as industries as diverse as
health care, defense and sports, adopt such technologies, researcher OG Analysis predicts. “We’re only at the beginning of this trend,” says Oliver Bendel, a professor at the University of Applied Sciences & Arts Northwestern Switzerland who specializes in machine ethics.